SEQENS
Seqens is a integrated in pharmaceutical synthesis and specialty ingredients, delivering unrivalled market responsiveness and tailor-made solutions to our customers.
SEQENS
Industry:
Biotechnology Pharmaceutical
Founded:
2003-01-01
Address:
Écully, Rhone-Alpes, France
Country:
France
Website Url:
http://www.seqens.com
Total Employee:
1001+
Status:
Active
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Content Delivery Network Apache Nginx
Current Employees Featured
Bob Huang Managing Director @ Seqens
Managing Director
2021-01-01
Pierre Luzeau CEO @ Seqens
CEO
Investors List
Merieux Developpement
Merieux Developpement investment in Private Equity Round - Seqens
Eurazeo
Eurazeo investment in Seed Round - Seqens
Key Employee Changes
| Date | New article |
|---|---|
| 2021-09-14 | Seqens Appoints Bob Huang Managing Director of North American CDMO Operations |
Official Site Inspections
http://www.seqens.com Semrush global rank: 668.33 K Semrush visits lastest month: 64.3 K
- Host name: seq1.awh.nexen.net
- IP address: 31.15.30.180
- Location: Lyon France
- Latitude: 45.748
- Longitude: 4.85
- Timezone: Europe/Paris
- Postal: 69009
More informations about "Seqens"
Group’s Governance - Seqens
Developing and implementing SEQENS’ strategy in line with the goup’s values. Each Exco member is also accountable for managing the performance of its business unit or function. …See details»
Manufacturer of pharmaceutical & specialty …
SEQENS is a world leader in the development and production of active ingredients, pharmaceutical intermediates, specialty ingredients and cosmetics and personal care products, with 16 production sites, 9 R&D centers and …See details»
COMMUNICATION ON PROGRESS - Seqens
SEQENS as a signatory of the UN GC since 2008, is committed to do everything possible to develop its business sustainability within the respect of the ten principles of the United Nations …See details»
SEQENS - LinkedIn
SEQENS | 40,399 followers on LinkedIn. Our science for your future | SEQENS is a worldwide leader in pharmaceutical solutions and specialty ingredients. The group generates a revenue …See details»
Seqens - Crunchbase Company Profile & Funding
Organization. Seqens . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Seqens is a integrated in pharmaceutical synthesis …See details»
SEQENS Company Profile - Office Locations, Competitors, Revenue …
SEQENS (previously known as Novacap) is a company specializing in pharmaceutical synthesis and specialty ingredients. It also offers a range of services including custom research and …See details»
Integrated leader of pharmaceutical ingredients - Seqens …
With 8 GMP, FDA inspected plants in Europe, the United States and Israel, Seqens conducts GMP manufacturing of small molecules APIs or intermediates from kilo to multi-ton quantities. …See details»
Custom Synthesis & Pharma Chemicals - Seqens
SEQENS, a global Contract Development and Manufacturing Organization With 25 years of experience in process development, scale-up and ongoing cGMP manufactu-ring of small …See details»
SEQENS. A New Name for a Global Leader in ... - Business Wire
Dec 19, 2018 SEQENS also develops custom solutions and ingredients for the most demanding industries such as healthcare, electronics, cosmetics, food and homecare. SEQENS. The …See details»
Employees and communities: our commitments - SEQENS
SEQENS is committed to ensure the safety and well-being of its employees, embrace diversity and maintain and promote our strong commitment to collaborations. ... the company can act in …See details»
We manufacture a wide range of active ingredients and functionals
Seqens Personal Care has built up a broad, cutting-edge offering for the cosmetics market, based on its pharmaceutical and fine chemistry expertise. Our company + Knowledge center. …See details»
Seqens Company Profile 2024: Valuation, Funding & Investors
Seqens General Information Description. Provider of pharmaceutical ingredients and specialty chemicals based in Ecully, France. The company specializes in aspirin, paracetamol, salicylic …See details»
SEQENS Makes Multi-Million-Dollar Investment in U.S. R&D …
Mar 21, 2022 SEQENS' investment signals major commitment to U.S. market and builds on merger with CDMO organization Wavelength Pharmaceuticals.See details»
Seqens Appoints Bob Huang Managing Director of North …
Sep 14, 2021 About Seqens CDMO North America Seqens CDMO North America (formerly PCI Synthesis) is a pharmaceutical development CDMO (Contract Development and …See details»
SEQENS. A New Name for a Global Leader in Pharmaceutical
Dec 19, 2018 Novacap, a global player in the pharmaceutical synthesis and specialty ingredients, with a broad portfolio of products and services and a wide range of technologies, …See details»
The CSR vision and strategy of the SEQENS Group - SEQENS
SEQENS CSR strategy addresses 13 of the 17 United Nations Sustainable Development Goals and is pursuing its continuous improvement efforts. United Nation Sustainable Development …See details»
Seqens - Overview, News & Similar companies | ZoomInfo.com
View Seqens (www.seqens.com) location in Massachusetts, France , revenue, industry and description. Find related and similar companies as well as employees by title and much more. …See details»
SEQENS - Careers website
Jul 12, 2024 Welcome to the Career Site for SEQENS Joining Seqens Group is a unique opportunity to participate in a growing, exciting project with a strong international dimension. …See details»
Our analytical solutions - Seqens Pharmaceutical Solutions
R&D is at the heart of Seqens’ strategy. With 10 centers of excellence around the world, including more than 300 researchers, 150 of whom are PhDs, Seqens has unique capabilities to support …See details»